Matches in SemOpenAlex for { <https://semopenalex.org/work/W2626025027> ?p ?o ?g. }
- W2626025027 endingPage "160" @default.
- W2626025027 startingPage "149" @default.
- W2626025027 abstract "Nowadays, colorectal cancer is the fourth most common type of tumor all over the world. When diagnosed, ∼50%-60% of tumors have metastasized, thus resulting in a grim prognosis. Chemotherapy is regarded as standard treatment for patients with colorectal cancer, however, limitations of chemotherapy cannot be ignored, such as low selectivity, insufficient concentrations in tumor tissues, and systemic toxicity. Recently, six targeted drugs have been approved by the U.S. Food and Drug Administration (FDA) for treatment of metastatic colorectal cancer (mCRC), including bevacizumab, aflibercept, regorafenib, cetuximab, and panitumumab. The development of these drugs marked significant advancement in the field of mCRC therapy. The addition of biologic agents to chemotherapy has prolonged the median overall survival. Now, many investigational drugs are under clinical trials, of which programmed death (PD)-1/L1 has drawn much attention. In this review, new biologic agents under clinical trials such as MEK/MET/RAS/RAF/PD-1 inhibitors with potentials for mCRC treatment are concluded by describing targeted drugs approved by FDA, to offer new insights into global trends and future development." @default.
- W2626025027 created "2017-06-23" @default.
- W2626025027 creator A5025581121 @default.
- W2626025027 creator A5044528533 @default.
- W2626025027 creator A5052267876 @default.
- W2626025027 creator A5064063139 @default.
- W2626025027 creator A5089843079 @default.
- W2626025027 date "2017-06-01" @default.
- W2626025027 modified "2023-10-03" @default.
- W2626025027 title "Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives" @default.
- W2626025027 cites W1503485936 @default.
- W2626025027 cites W1792294722 @default.
- W2626025027 cites W1940241680 @default.
- W2626025027 cites W1967628954 @default.
- W2626025027 cites W1968926036 @default.
- W2626025027 cites W1971208896 @default.
- W2626025027 cites W1978139448 @default.
- W2626025027 cites W1981486151 @default.
- W2626025027 cites W1982291583 @default.
- W2626025027 cites W2012169430 @default.
- W2626025027 cites W2012708129 @default.
- W2626025027 cites W2014013659 @default.
- W2626025027 cites W2014059088 @default.
- W2626025027 cites W2015132197 @default.
- W2626025027 cites W2018804685 @default.
- W2626025027 cites W2019925885 @default.
- W2626025027 cites W2021873050 @default.
- W2626025027 cites W2022594244 @default.
- W2626025027 cites W2026996188 @default.
- W2626025027 cites W2031797245 @default.
- W2626025027 cites W2035659380 @default.
- W2626025027 cites W2036227968 @default.
- W2626025027 cites W2036877832 @default.
- W2626025027 cites W2039123767 @default.
- W2626025027 cites W2051603178 @default.
- W2626025027 cites W2062109911 @default.
- W2626025027 cites W2064360454 @default.
- W2626025027 cites W2071697240 @default.
- W2626025027 cites W2079183075 @default.
- W2626025027 cites W2081890708 @default.
- W2626025027 cites W2083085047 @default.
- W2626025027 cites W2083898738 @default.
- W2626025027 cites W2085633477 @default.
- W2626025027 cites W2095201384 @default.
- W2626025027 cites W2097857976 @default.
- W2626025027 cites W2101368309 @default.
- W2626025027 cites W2103502575 @default.
- W2626025027 cites W2104237716 @default.
- W2626025027 cites W2104477408 @default.
- W2626025027 cites W2104759721 @default.
- W2626025027 cites W2106688644 @default.
- W2626025027 cites W2107467998 @default.
- W2626025027 cites W2108110723 @default.
- W2626025027 cites W2109462473 @default.
- W2626025027 cites W2111237964 @default.
- W2626025027 cites W2111358509 @default.
- W2626025027 cites W2112570485 @default.
- W2626025027 cites W2115735904 @default.
- W2626025027 cites W2121847974 @default.
- W2626025027 cites W2123548341 @default.
- W2626025027 cites W2124427232 @default.
- W2626025027 cites W2125616358 @default.
- W2626025027 cites W2125763124 @default.
- W2626025027 cites W2126163864 @default.
- W2626025027 cites W2127640925 @default.
- W2626025027 cites W2128041965 @default.
- W2626025027 cites W2130320283 @default.
- W2626025027 cites W2134519717 @default.
- W2626025027 cites W2135530224 @default.
- W2626025027 cites W2136781635 @default.
- W2626025027 cites W2139192665 @default.
- W2626025027 cites W2140587309 @default.
- W2626025027 cites W2140980839 @default.
- W2626025027 cites W2147297736 @default.
- W2626025027 cites W2147834058 @default.
- W2626025027 cites W2157410007 @default.
- W2626025027 cites W2160832584 @default.
- W2626025027 cites W2191562582 @default.
- W2626025027 cites W2234071502 @default.
- W2626025027 cites W2387426893 @default.
- W2626025027 cites W2541574334 @default.
- W2626025027 cites W2591615675 @default.
- W2626025027 cites W4211199921 @default.
- W2626025027 doi "https://doi.org/10.1089/cbr.2017.2210" @default.
- W2626025027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28622036" @default.
- W2626025027 hasPublicationYear "2017" @default.
- W2626025027 type Work @default.
- W2626025027 sameAs 2626025027 @default.
- W2626025027 citedByCount "80" @default.
- W2626025027 countsByYear W26260250272017 @default.
- W2626025027 countsByYear W26260250272018 @default.
- W2626025027 countsByYear W26260250272019 @default.
- W2626025027 countsByYear W26260250272020 @default.
- W2626025027 countsByYear W26260250272021 @default.
- W2626025027 countsByYear W26260250272022 @default.
- W2626025027 countsByYear W26260250272023 @default.
- W2626025027 crossrefType "journal-article" @default.
- W2626025027 hasAuthorship W2626025027A5025581121 @default.